sj-docx-1-aop-10.1177_10600280231218286 – Supplemental material for Risk of Fractures With Concomitant Use of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors

Supplemental material, sj-docx-1-aop-10.1177_10600280231218286 for Risk of Fractures With Concomitant Use of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors by Raj Desai, Steven M. Smith, Rajesh Mohandas, Joshua Brown and Haesuk Park in Annals of Pharmacotherapy</p

sj-docx-2-aop-10.1177_10600280221125919 – Supplemental material for Impact of Piperacillin-Tazobactam Dosing in Septic Shock Patients Using Real-World Evidence: An Observational, Retrospective Cohort Study

Supplemental material, sj-docx-2-aop-10.1177_10600280221125919 for Impact of Piperacillin-Tazobactam Dosing in Septic Shock Patients Using Real-World Evidence: An Observational, Retrospective Cohort Study by John M. Allen, Devi Surajbali, Dalena Q. Nguyen, Jolanta Kuczek, Maithi Tran, Brianna Hachey, Carinda Feild, Bethany R. Shoulders, Steven M. Smith and Stacy A. Voils in Annals of Pharmacotherapy</p